SusannaS.ParkMD
Ophthalmology • Sacramento, CARetinal Disease
Professor, Ophthalmology, UC, Davis School of Medicine
Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4860 Y St
Suite 2400
Sacramento, CA 95817Phone+1 916-734-6544Fax+1 916-734-6197
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1989 - 1992
Yale-New Haven Medical CenterInternship, Internal Medicine, 1988 - 1989
Yale School of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 1992 - 2026
TX State Medical License 1994 - 1999
MA State Medical License 1992 - 1996
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Super Doctor SuperDoctors.com
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration Start of enrollment: 2007 May 01
- ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD) Start of enrollment: 2010 Sep 01
- Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
- Join now to see all
Publications & Presentations
PubMed
- OCT Angiography Analysis of Retinal and Choroidal Flow after Proton Beam Therapy for Choroidal Melanoma.Su-Kyung Jung, Edward H Lee, Kavita K Mishra, Inder K Daftari, Susanna S Park
Ophthalmology Science. 2024-12-12 - 1 citationsInternational Classification System for Ocular Complications of Anti-VEGF Agents in Clinical Trials.Marko M Popovic, Michael Balas, SriniVas R Sadda, David Sarraf, Ryan Huang
Ophthalmology. 2024-12-01 - FUNGAL ENDOPHTHALMITIS MASQUERADING AS SYMPATHETIC OPHTHALMIA.Abraham Hang, Jonathan Ruiz, Susanna S Park, Natalie A Homer, Esther Kim
Retinal Cases & Brief Reports. 2024-09-01
Journal Articles
- Preliminary observation of a Phase 1 Trial of Intravitreal bone marrow CD34+ cell therapy for ischemic and degenerative retinopathyPark SS, Bauer G, Abedi M, et al, Invest Ophthalmol Vis Sci
Grant Support
- The Phase I/II Randomized, Prospective, Double-blinded, Sham-controlled Cross-over Study of Intravitreal Autologous Bone Marrow CD34+ Stem Cell Therapy for Retinal Vein OcclusionUNIVERSITY OF CALIFORNIA AT DAVIS2018–2025
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
